Focal Cortical Dysplasia
📧 Sign up to get email alerts when something new happens for Focal Cortical Dysplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II [Phase 1, Phase 2]
This clinical trial update describes Radiprodil in Phase 1/2 studies evaluating safety, tolerability, pharmacokinetics, and its effect on se…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME) [Phase 1, Phase 2]
Clinical trial update on SVG103 (paxalisib) evaluating safety, tolerability, and pharmacokinetics in focal cortical dysplasia type II, tuber…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs. [Phase 1]
Phase 1 open-label drug-drug interaction study of Radiprodil in the treatment of Tuberous Sclerosis Complex and Focal Cortical Dysplasia has…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Mos-FED (Mosaicism in Focal Epilepsy Cortical Dysplasia Tissue) [NA]
This document notes a clinical trial update for Mos-FED studying mosaicism in focal epilepsy cortical dysplasia tissue. The study is current…